Navigation Links
McKesson Expands Pharmacy Automation Product Portfolio to Include I.V. Therapy
Date:8/10/2009

BOZEN, Italy, August 10 /PRNewswire/ --

- Strategic Partnership Announced With Health Robotics

Health Robotics today announced that it has signed an exclusive five-year strategic partnership with McKesson for Health Robotics' CytoCare Robot. The agreement enables McKesson to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. admixtures.

"We are very pleased to have been chosen by Health Robotics as their exclusive CytoCare partner in our core markets of the United States and Canada", stated David Souerwine, President, McKesson Automation. "CytoCare, a-one-of-its-kind solution, represents an ideal complement to ROBOT-Rx(R) and MedCarousel(R) technologies, and our entire suite of Automation solutions."

McKesson believes that CytoCare has the potential to become the gold standard for Oncology I.V. admixtures in North America, equally protecting clinicians and patients. The successful installations of the CytoCare Robot in the United States, including the University of Colorado Hospital in Denver, show synergies between CytoCare and both McKesson Automation and other McKesson Provider Technologies market-leading solutions.

"McKesson is the ideal partner for Health Robotics in North America due to its commitment to medication safety, company stability, market footprint, world-class service infrastructure, and complementary oral medication automation technologies. I was extremely impressed to see their manufacturing and customer services operations in Pittsburgh; they are exactly what CytoCare customers need in North America: a knowledgeable, committed, resourceful, and customer-focused organization. This is precisely what Health Robotics requires at this moment in time to take CytoCare to the next level of market acceptance and customer-service focus in North America. I'm sure this is just the beginning of a long-term partnership expanding into manufacturing and other fields of I.V. Robotics Automation", stated Werner Rainer, Chairman and CEO of Health Robotics.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to ease global hospitals' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, visit http://www.health-robotics.com

About McKesson:

McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. McKesson has been in continuous operation for more than 175 years, making it the longest-operating company in healthcare today. Over the course of its history, McKesson has grown by providing pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. For more information, visit http://www.mckesson.com

    For additional information, please contact:
    Health Robotics S.r.l.
    Gaspar G. DeViedma
    Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100
    USA: +1-609-980-7976
    EUROPE: +39-346-963-4934
    gaspar.deviedma@health-robotics.com

    McKesson Corporation
    Clay Courville
    Vice President, Marketing
    +1-724-741-8111
    clay.courville@mckesson.com



'/>"/>
SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. 14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging
2. BIO-key(R) Biometric Identification Solution Deployed by McKesson
3. PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKessons Patent Application
4. Artromick Aligns with McKesson to Enhance Medication Safety at the Patients Bedside
5. iCardiac Expands Sales and Marketing Team
6. Zeus Expands International Support With New Hires
7. Digitas Health Expands Adding Two Key Locations
8. GenVec Expands Contract Supporting Malaria Vaccine Program
9. Biomodels Expands Efforts in Cancer Supportive Care, Pulmonary Fibrosis; Preclinical Research Organization Names Dr. Stephen T. Sonis as Partner
10. Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors
11. Regado Biosciences Expands Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... has an active R&D program for the development ... the Group has a unique research and development center in ... developing Bio Control products. Stockton has ... and regulatory guidelines, and is active in more than 35 ... Stockton,s flagship product Timorex Gold ® ...
(Date:2/6/2016)... ... February 06, 2016 , ... Contact:, Abby Mitchell, Communications Manager, ... Education Sponsors Teacher Training Program , Bite of Science Dinner Event to Strengthen ... Excellence in Education (CEE) will sponsor a Bite of Science professional enrichment session, ...
(Date:2/5/2016)... 2016 Amarantus BioScience Holdings, Inc. ... on developing products for Regenerative Medicine, Neurology and Orphan ... Designation (RPDD) from the US Food and Drug Administration ... was previously granted orphan drug designation (ODD) by the ... BioScience Holdings, Inc. (OTCQB: AMBS), a ...
(Date:2/4/2016)... RICHMOND, Calif. , Feb. 4, 2016  Sangamo ... therapeutic genome editing, announced today that Edward Lanphier ... an update on the progress of Sangamo,s ZFP Therapeutic ... company,s business strategy at 2:40 pm ET on Thursday, ... Annual Global Healthcare Conference. The conference is being ...
Breaking Biology Technology:
(Date:1/22/2016)... 22, 2016 ... of the  "Global Behavioral Biometric Market ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ... Biometric Market 2016-2020"  report to their ... Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
(Date:1/13/2016)... New York , January 13, 2016 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2023. According to the ... in 2014 and is anticipated to reach US$1,625.8 mn ... 2015 to 2023. In terms of volume, the biometric ...
Breaking Biology News(10 mins):